Literature DB >> 8948491

Slow-binding inhibition: the general case.

M J Sculley1, J F Morrison, W W Cleland.   

Abstract

Two basic kinetic mechanisms have been described to account for the slow-binding inhibition of enzyme-catalyzed reactions. One mechanism involves the slow interaction of an inhibitor with enzyme (Mechanism A), while the other involves the rapid formation of an enzyme-inhibitor complex that undergoes a slow isomerization reaction (Mechanism B). But the initial interaction of enzyme and inhibitor may not necessarily be fast so that the free enzyme and the two forms of enzyme inhibitor complex are in steady-state equilibrium. This assumption would give rise to a more general form of Mechanism B. The present study has been concerned with attempts to determine whether it might be possible to distinguish between the three possible inhibition mechanisms by steady-state kinetic techniques. The approach to the investigation has been to derive theoretical data for the most general mechanism by using three different ratios for the two rate constants that determine which mechanism applies. The progress curve data were then fitted to the rate equations that describe the other two mechanisms. The results draw attention to the difficulties of deducing that experimental data conform to the most general mechanism. They also show how the values for the kinetic parameters, as determined from fits of the data to the equations that describe Mechanisms A and B, can be considerably in error.

Mesh:

Substances:

Year:  1996        PMID: 8948491     DOI: 10.1016/s0167-4838(96)00118-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Kinetic mechanisms of inhibitor binding: relevance to the fast-acting slow-binding paradigm.

Authors:  S Falk; N Oulianova; A Berteloot
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

2.  Kinetic and inhibition studies of dihydroxybenzoate-AMP ligase from Escherichia coli.

Authors:  Alison L Sikora; Daniel J Wilson; Courtney C Aldrich; John S Blanchard
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

Review 3.  Mechanistic enzymology in drug discovery: a fresh perspective.

Authors:  Geoffrey A Holdgate; Thomas D Meek; Rachel L Grimley
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

4.  Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.

Authors:  Mili Kapoor; C Chandramouli Reddy; M V Krishnasastry; Namita Surolia; Avadhesha Surolia
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

5.  Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).

Authors:  Scott D Seiwert; Steven W Andrews; Yutong Jiang; Vladimir Serebryany; Hua Tan; Karl Kossen; P T Ravi Rajagopalan; Shawn Misialek; Sarah K Stevens; Antitsa Stoycheva; Jin Hong; Sharlene R Lim; Xiaoli Qin; Robert Rieger; Kevin R Condroski; Hailong Zhang; Mary Geck Do; Christine Lemieux; Gary P Hingorani; Dylan P Hartley; John A Josey; Lin Pan; Leonid Beigelman; Lawrence M Blatt
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

Review 6.  Glycosidase inhibition: assessing mimicry of the transition state.

Authors:  Tracey M Gloster; Gideon J Davies
Journal:  Org Biomol Chem       Date:  2009-11-05       Impact factor: 3.876

7.  Characterization of Folic Acid and Poly(amidoamine) Dendrimer Interactions with Folate Binding Protein: A Force-Pulling Study.

Authors:  Pascale R Leroueil; Stassi DiMaggio; Abigail N Leistra; Craig D Blanchette; Christine Orme; Kumar Sinniah; Bradford G Orr; Mark M Banaszak Holl
Journal:  J Phys Chem B       Date:  2015-08-14       Impact factor: 2.991

8.  Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the methylerythritol phosphate pathway.

Authors:  Karnjapan Janthawornpong; Sergiy Krasutsky; Philippe Chaignon; Michel Rohmer; C Dale Poulter; Myriam Seemann
Journal:  J Am Chem Soc       Date:  2013-01-29       Impact factor: 15.419

9.  Solvent-assisted slow conversion of a dithiazole derivative produces a competitive inhibitor of peptide deformylase.

Authors:  Alexander K Berg; Qingfeng Yu; Steven Y Qian; Manas K Haldar; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2009-11-14

10.  Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.

Authors:  Lionel Kuntz; Denis Tritsch; Catherine Grosdemange-Billiard; Andréa Hemmerlin; Audrey Willem; Thomas J Bach; Michel Rohmer
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.